Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
R. O'Donoghue (Melbourne, Australia), C. O'Brien (Melbourne, Australia), M. Chuei (Melbourne, Australia), V. Welk (Freising, Germany), T. Jaquin (Freising, Germany), G. Martic (Freising, Germany), E. Cho (Melbourne, Australia), K. Stok (Melbourne, Australia), D. Haugan (Melbourne, Australia), G. Matschiner (Freising, Germany), G. Ciccotosto (Melbourne,, Australia), A. Jarnicki (Melbourne, Australia), G. Anderson (Melbourne, Australia)
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. O'Donoghue (Melbourne, Australia), C. O'Brien (Melbourne, Australia), M. Chuei (Melbourne, Australia), V. Welk (Freising, Germany), T. Jaquin (Freising, Germany), G. Martic (Freising, Germany), E. Cho (Melbourne, Australia), K. Stok (Melbourne, Australia), D. Haugan (Melbourne, Australia), G. Matschiner (Freising, Germany), G. Ciccotosto (Melbourne,, Australia), A. Jarnicki (Melbourne, Australia), G. Anderson (Melbourne, Australia). Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice. 733
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019
Transient over-expression of bioactive PDGF-BB induces lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006
PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013
Attenuation of bleomycin-induced pulmonary fibrosis by direct thrombin inhibition is accompanied by a reduction in connective tissue growth factor mRNA levels Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001
Naftopidil, a selective a1 adrenoceptor antagonist, inhibits the growth of lung fibroblasts and attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017
Synergistic role of HSP90a and HSP90ß to promote myofibroblast persistence in lung fibrosis Source: Eur Respir J, 51 (2) 1700386; 10.1183/13993003.00386-2017 Year: 2018
Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008
Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA Source: International Congress 2015 – Interstitial lung diseases II Year: 2015
FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018
Enhanced expression of Robo4 ameliorates LPS-induced acute lung injury in mice Source: Annual Congress 2011 - Acute respiratory failure Year: 2011
Transient transgene expression of CTGF in the lung induces moderate and reversible fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 378s Year: 2002
Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed SOD2 expression and reduces proliferation in human primary pulmonary fibroblasts Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013
Upregulated of NO-synthesising lung activity and its correction in LPS-induced lung injury in mice Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004
Extracellular HSP90a promotes pulmonary fibrosis by impairing autophagic flux in lung fibroblasts Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015
Dexamethasone reduces lung inflammation induced by alveolar stretch in mice Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011
CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages Source: Eur Respir J, 51 (3) 1702120; 10.1183/13993003.02120-2017 Year: 2018
Alteration of eicosanoid metabolism/signalling in IL-9 overexpressing mice and impact on lung fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 575s Year: 2007